References
- Anderson L, Moore J, Kruijshaar M, Pedrazzoli D, Bradshaw L, Crofts J. Tuberculosis in the UK: report on tuberculosis surveillance in the UK 2010. Health Protection Agency 2010. Available at: http://www.hpa.org.uk (accessed 14 October 2012).
- Stopping tuberculosis in England: an action plan from the Chief Medical Officer. London: Department of Health;2004.
- Tuberculosis prevention and treatment:a toolkit for planning, commissioning and delivering high-quality services in England. London: Department of Health;2007.
- Dowdy DW, Chaisson RE, Maartens G, Corbett EL, Dorman SE. Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. PNAS 2008;105:11293–8.
- Gardy JL, Johnston JC, Shannan JHS, Cook V, Shah L, Brodkin E. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 2011; 364:730–9.
- Parrish NM, Carroll KC. Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settings. J Clin Microbiol 2011;49:772–6.
- Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE Clinical Guidelines CG117. London: National Institute for Health and Clinical Excellence; 2011.
- Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54: 49–55.
- Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, Mwansa-Kambafwile J, et al. Predictive value of interferon gamma release assays for incident active tuberculosis: a systematic review and meta analysis. Lancet Infect Dis 2012; 12:45–55.
- Lalvani A, Richeldi L, Kunst H. Interferon gamma assays for tuberculosis. Lancet Infect Dis 2005;5:322–4.
- Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, et al. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 2007;45:837–45.
- Korzeniewska-Kosela M, Krysl J, Müller N, Black W, Allen E, FitzGerald JM. Tuberculosis in young adults and the elderly. A prospective comparison study. Chest 1994; 106: 28–32.
- Leung CC, Yew CC, Chan CK, Chau CH, Tam CM, Lam CW, et al. Tuberculosis in older people: a retrospective and comparative study from Hong Kong. J Am Geriatr Soc 2002;50:1219–26.
- Laifer G, Widmer AF, Simcock M, Bassetti S, Trampuz A, Frei R, et al. TB in a low-incidence country: differences between new immigrants, foreign-born residents and native residents. Am J Med 2007;120:350–6.
- Al-Nakeeb Z, Gupta V, Bell C, Woodhead MP. Are we missing opportunities to obtain a microbiological diagnosis of TB?. Thorax 2010;65:A103–4.
- Thyssen JP, Lillebaek T, Andersen PH, Kok-Jensen A, Thomsen VO. Tuberculosis not verified by culture in a low incidence country. Scand J Infect Dis 2004;36: 807–10.
- Sreeramareddy CT, Panduru KV, Menten J, Ende JV. Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect Dis 2009;9:91.
- Farah MG, Rygh JH, Steen TW, Selmer R, Heldal E, Bjune G. Patient and health care system delays in the start of tuberculosis treatment in Norway. BMC Infect Dis 2006; 6:33.
- Saldana L, Abid M, McCarthy N, Hunter N, Inglis R, Anders K. Factors affecting delay in initiation of treatment of tuberculosis in the Thames Valley, UK. Public Health 2013; 127:171–7.
- Cutler RR, Baithun SI, Doran HM, Wilson P. Association between the histological diagnosis of tuberculosis and microbiological findings. Tuber Lung Dis 1994;75:75–9.